Carbon nanotubes as nanomedicines: from toxicology to pharmacology.
By Lara Lacerda, A. Bianco, M. Prato, Kostas Kostarelos. Advanced Drug Delivery Reviews, 2006
787 citations recorded by the source corpus.
Various biomedical applications of carbon nanotubes have been proposed in the last few years leading to the emergence of a new field in diagnostics and therapeutics. Most of these applications will involve the administration or implantation of carbon nanotubes and their matrices into patients. The toxicological and pharmacological profile of such carbon nanotube systems developed as nanomedicines will have to be determined prior to any clinical studies undertaken. This review brings together all the toxicological and pharmacological in vivo studies that have been carried out using carbon nanotubes, to offer the first summary of the state-of-the-art in the pharmaceutical development of carbon nanotubes on the road to becoming viable and effective nanomedicines.
Subfields: Biomedical Engineering, Materials Chemistry
View Paper: https://www.semanticscholar.org/paper/5f64c58e89b907ad2589071d69da69da70bfef90
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Biomedical Engineering
In Materials Chemistry
Citations in the corpus
- Carbon nanotubes for biological and biomedical applications (2007, background): “The combination of these characteristics make CNTs unique materials with the potential for diverse applications [75–84].”
- In vivo pharmacokinetics, long-term biodistribution, and toxicology of PEGylated graphene in mice. (2011, background): “novel nanomaterials can be translated into the clinic.(4) 6 Graphene, single or few layers of sp(2)-bonded carbon, has attracted tre-”
- Effects of nanomaterial physicochemical properties on in vivo toxicity (2009, neutral): “4-100 nm and can be up to several microns long [58].”
- Carbon nanotubes: properties, synthesis, purification, and medical applications (2014, background): “In and administered to BALB/c mice to evaluate the biodistribution of nanotubes [80].”